Reported about 1 month ago
Galderma's private equity backers are set to sell a $1.2 billion stake in the skincare company after a successful initial public offering, which saw shares rise by 52% since March. The sale, representing a 5.5% stake, is being coordinated by major investment banks, and there is strong demand from investors. This follows a broader trend of private equity firms offloading stakes in European companies after notable IPO performances.
Source: YAHOO